Skip to main content
Prospectus Disclaimer

Important Notice

BEFORE DOWNLOADING, PRINTING OR VIEWING THE PROSPECTUS, PLEASE CAREFULLY READ THIS INFORMATION.

Prospectus

The prospectus dated 21 January 2022 (Prospectus) is an important document that should be read in its entirety before deciding whether to participate in the Offer (as referred to below and detailed in the Prospectus). If after reading the Prospectus, you have questions about the Offer, you should contact your stockbroker, accountant or other professional adviser.

The Offer

The Prospectus contains details of an offer by Many Peaks Gold Limited ACN 642 404 797 (Company) for fully paid ordinary shares in the Company (Shares) as set out in the Prospectus (Offer). The Offer is subject to a minimum subscription as described in the Prospectus. No Shares will be issued on the basis of the Prospectus after the expiry date, being 13 months after the date of the Prospectus. The Company will apply to the Australian Securities Exchange (ASX) for admission to the official list of ASX and quotation of the Shares on ASX within seven days of the date of the Prospectus.

Important Information

The paper form of the Prospectus is available electronically through this website. A free paper copy of the Prospectus is available from the Company upon request by an eligible investor.

Neither ASIC nor ASX (or their respective officers) take any responsibility for the contents of the Prospectus or the merits of the investment to which it relates.

The information contained in the Prospectus is not financial product advice and does not take into account your investment objectives, financial situation or particular needs. The Prospectus should not be construed as financial, taxation, legal or other advice. The Company is not licensed to provide financial product advice in respect of its securities or any other financial products.

The Prospectus is important and should be read in its entirety prior to deciding whether to invest in the Company. There are risks associated with an investment in the Company and some of the key risks are set out in the Prospectus. You should carefully consider these risks in light of your personal circumstances (including financial and tax issues) and seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser before deciding whether to invest in the Company. There may also be risks in addition to these that should be considered in light of your personal circumstances.

If you do not fully understand the Prospectus or are in doubt as to how to deal with it, you should seek professional guidance from your stockbroker, solicitor, accountant, financial adviser or other independent professional adviser before deciding whether to invest in the Company.

No person or entity named in the Prospectus warrants or guarantees the Company’s performance, the repayment of capital by the Company or any return on investment made pursuant to the Prospectus.

This notice does not form part of the Prospectus. You must read it before you attempt to access the electronic version of the Prospectus on this website and indicate your agreement or otherwise at the bottom of this notice.

Warning

The distribution of the Prospectus outside of Australia may be restricted by law. The Prospectus is not intended to, and does not, constitute an offer of securities in any place which, or to any person to whom, the making of such offer would not be lawful under the laws of any jurisdiction outside Australia. The failure to comply with any applicable restrictions may constitute a violation of securities law in those jurisdictions.

No action has been taken to register or qualify the securities or the Offer under the Prospectus or otherwise to permit a public offering of the securities in any jurisdiction outside Australia. The distribution of the Prospectus (including in electronic form) outside Australia may be restricted by law and persons. The Prospectus accessible on this website may not be accessed by persons outside Australia or forwarded to persons outside Australia. Any failure to comply with such restrictions may constitute a violation of applicable securities laws. The return of a duly completed Application Form or making of the application payment for Shares by BPAY® will be taken by Computershare and the Company to constitute a representation and a warranty made by the applicant to Computershare and to the Company that there has been no breach of such laws and that all necessary approvals and consents have been obtained.

The Shares have not been, nor will be, registered under the US Securities Act of 1933 or the securities laws of any state or other jurisdiction of the United States. The Shares may not be offered, sold or resold, directly or indirectly, in the United States except in transactions exempt from, or not subject to the registration requirements of the US Securities Act and applicable US state securities laws. The Prospectus does not constitute an offer of Shares in the United States and Shares will not be offered or sold, directly or indirectly, to persons in the United States.

The Prospectus accessible on this website is available to residents of Australia accessing the site from in Australia only. If you are accessing this site from anywhere outside Australia or are not a resident of Australia, do not download, print or view the Prospectus. By accessing the Prospectus, you acknowledge and confirm, among other things, that you are an Australian resident and are accessing the site from within Australia.

You should ensure that any copy of the Prospectus you view or print is complete. To the extent permitted by law, the Company is not liable for any loss incurred from accessing or downloading the Prospectus from this website, including, but not limited to, data corruption on download.

Exposure Period

The Corporations Act 2001 (Cth) (Corporations Act) prohibits the Company from processing applications for securities under the Prospectus (Applications) in the seven-day period after the date of lodgement of the Prospectus with ASIC (Exposure Period). This period may be extended by ASIC for a further period of up to seven days. The purpose of the Exposure Period is to enable the Prospectus to be examined by ASIC and market participants prior to the raising of funds under the Offer. The examination may result in the identification of deficiencies in the Prospectus, in which case any Application may need to be dealt with in accordance with section 724 of the Corporations Act. Applications received during the Exposure Period will not be processed until after the expiry of the Exposure Period. No preference will be conferred on any Applications received during the Exposure Period.

Acknowledgement

The information on this website is provided for information purposes only and is subject to change without notice. Nothing contained on this website or in the Prospectus constitutes investment, legal, business, taxation or other advice. The information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs.

By clicking the ‘I CONFIRM’ button below and accessing the Prospectus on this website, you acknowledge that you have read and accept the terms set out in this notice and represent, warrant and agree that:

  1. you are a resident of Australia accessing this website from within Australia;
  2. you are 18 years of age or over;
  3. you are not a resident of the United States nor currently located in the United States;
  4. you are not acting for the account nor benefit of a person in the United States or any other foreign person;
  5. you will not make a copy of the Prospectus available to, or release or distribute a copy of the Prospectus to, or for the account or benefit of, any person in the United States or in any other place in which, or to any other person to whom, it would be unlawful to do so (Ineligible Persons); and
  6. you are not acting as a nominee for, or otherwise for the account or benefit of, any Ineligible Persons.
I CONFIRM